2021
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI et. al.Základní údaje
Originální název
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
Autoři
NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI, Z. M. QIU, O. Y. MANSOUR, A. SATHYA, A. CZLONKOWSKA, G. TSIVGOULIS, D. A. DE SOUSA, J. DEMEESTERE, Robert MIKULÍK (203 Česká republika, garant, domácí), P. VANACKER, J. E. SIEGLER, J. KORV, J. BILLER, C. W. LIANG, N. S. SANGHA, A. M. ZHA, A. L. CZAP, C. A. HOLMSTEDT, T. N. TURAN, G. NTAIOS, K. MALHOTRA, A. TAYAL, A. LOOCHTAN, A. RANTA, E. A. MISTRY, A. W. ALEXANDROV, D. Y. HUANG, S. YAGHI, E. RAZ, S. A. SHETH, M. H. MOHAMMADEN, M. FRANKEL, E. G. B. LAMOU, H. M. AREF, A. ELBASSIOUNY, F. HASSAN, T. MENECIE, W. MUSTAFA, H. M. SHOKRI, T. ROUSHDY, F. S. SARFO, T. O. ALABI, B. ARABAMBI, E. O. NWAZOR, T. A. SUNMONU, K. WAHAB, J. YARIA, H. H. MOHAMMED, P. B. ADEBAYO, A. D. RIAHI a Sassi S. BEN
Vydání
Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2021, 0028-3878
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 11.800
Kód RIV
RIV/00216224:14110/21:00122752
Organizační jednotka
Lékařská fakulta
UT WoS
000702399700021
Klíčová slova anglicky
COVID-19; Stroke Care; IV Thrombolysis
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 8. 2. 2022 10:30, Mgr. Tereza Miškechová
Anotace
V originále
Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.
Návaznosti
90128, velká výzkumná infrastruktura |
|